Search
Methyl pyrrolidone
go.drugbank.com/drugs/DB12521InvestigationalN Methyl Pyrrolidone is under investigation for the treatment of Multiple Myeloma.
Synonyms: 1-methyl-2-pyrrolidinone, 1-methyl-2-pyrrolidoneCategories: Heterocyclic Compounds, 1-RingLecozotan
go.drugbank.com/drugs/DB12540InvestigationalLecozotan has been used in trials studying the treatment of Alzheimer Disease.
Categories: Heterocyclic Compounds, 1-Ring, Serotonin 5-HT1 Receptor AntagonistsFK-614
go.drugbank.com/drugs/DB12557InvestigationalFK614 has been used in trials studying the treatment of Diabetes Mellitus.
JNJ-37822681
go.drugbank.com/drugs/DB12579InvestigationalJNJ-37822681 has been used in trials studying the treatment of Schizophrenia.
Categories: Heterocyclic Compounds, 1-RingBMS-911543
go.drugbank.com/drugs/DB12591InvestigationalBMS-911543 has been used in trials studying the treatment of Cancer.
Categories: Janus Kinase 2, antagonists & inhibitorsGSK-1292263
go.drugbank.com/drugs/DB12627InvestigationalGSK1292263 has been investigated for the treatment of DIABETES MELLITUS, TYPE 2.
Azeliragon
go.drugbank.com/drugs/DB12689InvestigationalAzeliragon has been used in trials studying the treatment of Alzheimer's Disease.
Categories: Heterocyclic Compounds, 1-RingGavestinel
go.drugbank.com/drugs/DB06741ExperimentalHighly potent and selective non-competitive antagonist acting at the strychnine-insensitive glycine binding site of the NMDA receptor-channel complex (Kd = 0.8 nM). … Gavestinel displays > 1000-fold selectivity over NMDA, AMPA and kainate binding sites and is orally bioavailable and active in vivo.
Categories: Heterocyclic Compounds, 2-RingLatrunculin A
go.drugbank.com/drugs/DB02621InvestigationalLatrunculin A is an actin binding macrolide purified from the red sea sponge Latrunculia magnifica. It is under investigation for the treatment of cancer.
Synonyms: (4R)-4-[(1R,4Z,8E,10Z,12S,15R,17R)-17-hydroxy-5,12-dimethyl-3-oxo-2,16-dioxabicyclo[13.3.1]nonadeca-4,8,10-trien-17-yl]-1,3-thiazolidin-2-one, LAT-AMVR-T3011
go.drugbank.com/drugs/DB17378InvestigationalMVR-T3011 is a genetically modified oncolytic Herpes Simplex Virus (HSV-1) with 2 exogenous genes encoding the active heterodimer human interleukin 12 (IL-12) and the Fab fragment of an anti-human PD-1